ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Impact of a Steroid Free Immunosuppressive Regimen on Patient and Graft Outcomes in Pancreas Transplant Recipients

M. Cote,1 C. Rogers,1 K. Khwaja,2 A. Evenson,2 M. Pavlakis,2 K. Richards.1

1Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA
2Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA.

Meeting: 2018 American Transplant Congress

Abstract number: A352

Keywords: Graft failure, Immunosuppression, Rejection, Survival

Session Information

Date: Saturday, June 2, 2018

Session Name: Poster Session A: Pancreas and Islet: All Topics

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall 4EF

Related Abstracts
  • The Effect of Steroid Maintenance in Recipients with Pancreas Transplant Alone: A Single Center Experience
  • Long-Term Outcomes of a Steroid-Free, Belatacept-Based Immunosuppressive Regimen Plus Sirolimus Using Alentuzumab Induction in Renal Transplantation

Steroids have been an important component of maintenance immunosuppression in solid organ transplant, but their adverse effect profile has led to the development of steroid withdrawal regimens. In pancreas transplant, steroid withdrawal regimens have been studied but long term data is lacking. The purpose of this study was to evaluate steroid withdrawal on patient and graft outcomes in pancreas transplant recipients at three years post-transplant.

Methods: We performed a retrospective chart review of adult patients who underwent a pancreas transplant at our center between May 1989 and October 2013. Maintenance immunosuppression consisted of tacrolimus, mycophenolate mofetil or sodium and prednisone until 2004 when a steroid withdrawal protocol was adopted. The primary outcome was the composite of graft survival, patient survival and rejection at three years post-transplant. Secondary outcomes include readmission rates at one month and three months post-transplant, immunosuppression levels, incidence of infection, and the number of patients who resumed prednisone in the steroid free group.

Results: A total of 123 pancreas transplant recipients were included, 70 patients continued steroids and 53 patients underwent steroid withdrawal. The study population consisted of male (57.7%) Caucasians (88.3%) at a mean age of 42.78 ± 7.25 years. There was no difference in the composite endpoint of patient death, graft loss or rejection between groups (steroid-based vs. steroid-free) at three years (36% vs. 28%, p=0.38). There was no difference between groups in readmission at one month (59% vs 66%, p=0.46) and three months (46% vs 45%, p=0.96). Tacrolimus troughs were not different between groups at any timepoint. The MMF dose was significantly lower in the steroid-free group at three years compared to the steroid group (1214mg vs. 1656mg, p=0.02). The total number of infections at 36 months was numerically higher (117 vs. 64) in the patients maintained on steroids.

Conclusion: When evaluating the composite endpoint, pancreas transplant recipients on a steroid-free regimen do not appear to be at increased risk of graft loss, patient death or rejection. Avoidance of long term prednisone may reduce the risk of infectious complications post-pancreas transplant.

CITATION INFORMATION: Cote M., Rogers C., Khwaja K., Evenson A., Pavlakis M., Richards K. Impact of a Steroid Free Immunosuppressive Regimen on Patient and Graft Outcomes in Pancreas Transplant Recipients Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Cote M, Rogers C, Khwaja K, Evenson A, Pavlakis M, Richards K. Impact of a Steroid Free Immunosuppressive Regimen on Patient and Graft Outcomes in Pancreas Transplant Recipients [abstract]. https://atcmeetingabstracts.com/abstract/impact-of-a-steroid-free-immunosuppressive-regimen-on-patient-and-graft-outcomes-in-pancreas-transplant-recipients/. Accessed December 11, 2019.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Penis Transplantation: First U.S. Experience.
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
  • CNI-Free Therapy with Iscalimab (anti-CD40 mAb) Preserves Allograft Histology Compared to Standard of Care after Kidney Transplantation
  • CFZ533, a New Anti-CD40 mAB Demonstrates Comparable Efficacy and Better Renal Function versus Tacrolimus in De-Novo CNI-Free Kidney Transplantation
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2019 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

wiley-new-logo

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.